@prefix dcterms: . @prefix foaf: . @prefix wdrs: . @prefix owl: . @prefix xsd: . @prefix gr: . @prefix xml: . @prefix vcard: . @prefix dc: . @prefix rdf: . @prefix rdfs: . @prefix pto: . @prefix schema: . # OWL DL work-arounds (instead of imports) dc:contributor a owl:AnnotationProperty. dc:creator a owl:AnnotationProperty. dc:rights a owl:AnnotationProperty. dc:subject a owl:AnnotationProperty. dc:title a owl:AnnotationProperty. dcterms:license a owl:AnnotationProperty. wdrs:describedby a owl:AnnotationProperty. foaf:Document a owl:Class. foaf:homepage a owl:AnnotationProperty. foaf:page a owl:AnnotationProperty. foaf:primaryTopic a owl:AnnotationProperty. schema:Product a owl:Class. #OWL 1 DL compatibility of the OWL2 deprecated property owl:deprecated a owl:AnnotationProperty. a owl:Ontology; dc:title "PTO: The Product Types Ontology for Semantic Web-based E-Commerce"@en; rdfs:comment """The Product Types Ontology: Good identifiers for product types based on Wikipedia This service provides GoodRelations-compatible class definitions for any type of product or service that has an entry in the English Wikipedia. Vocabulary: http://www.productontology.org/# Namespace: http://www.productontology.org/ The Product Types Ontology is designed to be used in combination with GoodRelations, a standard vocabulary for the commercial aspects of offers. See http://purl.org/goodrelations/ for more information."""@en; rdfs:label "The Product Types Ontology for Semantic Web-based E-Commerce"@en; dc:contributor "The class abstracts and translations of labels are taken from Wikipedia, the free encyclopedia."@en; dc:creator "Martin Hepp"@en; dc:rights "The class definition texts are taken from Wikipedia, the free encyclopedia under a Creative Commons Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0) license, see http://creativecommons.org/licenses/by-sa/3.0/. Accordingly, all ontology class definitions provided in here are available under the very same license."@en; dc:subject "E-Commerce, E-Business, GoodRelations, Ontology, Wikipedia, DBPedia"@en; dcterms:license ; rdfs:seeAlso ; owl:imports ; owl:versionInfo "2026-04-09T02:11:50.926818". a foaf:Document; foaf:primaryTopic . a foaf:Document; foaf:primaryTopic . a foaf:Document; foaf:primaryTopic . a foaf:Document; foaf:primaryTopic . a owl:Class; rdfs:subClassOf gr:ProductOrService, schema:Product; rdfs:label "Pharmaceutical industry"@en; rdfs:comment """The pharmaceutical industry is a medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications. Medications are then administered to (or self-administered by) patients for curing or preventing disease or for alleviating symptoms of illness or injury. Generic drugs are typically not protected by patents, whereas branded drugs are covered by patents. The industry's various subdivisions include distinct areas, such as manufacturing biologics and total synthesis. The industry is subject to a variety of laws and regulations that govern the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceutical market was valued at approximately US$1.48 trillion in 2022, reflecting steady growth from 2020 and continuing expansion despite the impacts of the COVID-19 pandemic. The sector showed a compound annual growth rate (CAGR) of 1.8% in 2021, including the effects of the COVID-19 pandemic. In historical terms, the pharmaceutical industry, as an intellectual concept, arose in the middle to late 1800s in nation-states with developed economies such as Germany, Switzerland, and the United States. Some businesses engaging in synthetic organic chemistry, such as several firms generating dyestuffs derived from coal tar on a large scale, were seeking out new applications for their artificial materials in terms of human health. This trend of increased capital investment occurred in tandem with the scholarly study of pathology as a field advancing significantly, and a variety of businesses set up cooperative relationships with academic laboratories evaluating human injury and disease. Examples of industrial companies with a pharmaceutical focus that have endured to this day after such distant beginnings include Bayer (based out of Germany) and Pfizer (based out of the U.S.). The pharmaceutical industry has faced extensive criticism for its marketing practices, including undue influence on physicians through pharmaceutical sales representatives, biased continuing medical education, and disease mongering to expand markets. Pharmaceutical lobbying has made it one of the most powerful influences on health policy, particularly in the United States. There are documented cases of pharmaceutical fraud, including off-label promotion and kickbacks, resulting in multi-billion dollar settlements. Drug pricing continues to be a major issue, with many unable to afford essential prescription drugs. Regulatory agencies like the FDA have been accused of being too lenient due to revolving doors with industry. During the COVID-19 pandemic, major pharmaceutical companies received public funding while retaining intellectual property rights, prompting calls for greater transparency and access. (Source: Wikipedia, the free encyclopedia, see http://en.wikipedia.org/wiki/Pharmaceutical_industry)"""@en; rdfs:isDefinedBy ; rdfs:label "صناعة الدواء"@ar; rdfs:label "Фармацевтична промишленост"@bg; rdfs:label "ঔষধনির্মাণ শিল্প"@bn; rdfs:label "Indústria farmacèutica"@ca; rdfs:label "Diwydiant fferyllol"@cy; rdfs:label "Lægemiddelindustri"@da; rdfs:label "Φαρμακευτική βιομηχανία"@el; rdfs:label "Farmacia industrio"@eo; rdfs:label "Industria farmacéutica"@es; rdfs:label "Farmazia industria"@eu; rdfs:seeAlso , , ; wdrs:describedby , ; foaf:homepage ; foaf:page .